Winnie H. Wan

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Dot Edu Ventures is an independent venture capital firm founded in 2000 by Asha Jadeja. The firm is headquartered in Palo Alto, California.

Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts.

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX.

Popper & Co. LLC is a strategy consulting and transaction advisory firm. It serves the medical technology and life sciences industries. The company was founded by Caroline Popper and Kenneth G. Walz on June 1, 2003 and is headquartered in Baltimore, MD.

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

AX Enterprize LLC specializes in hardware, software and systems engineering and light electro-mechanical manufacturing. It also designs and develops hardware components and cable harnesses (copper and fiber) for airborne, land vehicle assets and terrestrial installations. The company is headquartered in Yorkville, NY.

BioAgilytix Labs LLC engages in the provision of specialized bioanalytical testing laboratory. It offers gene therapy, biosimilars, antibody drug conjugates and immuno-oncology solutions. The company was founded by Afshin Safavi in 2008 and is headquartered in Durham, NC.

StepStoneMed, Inc. develops software which acquires and retain clinical knowledge and recall patient care protocols. Its software is used by the physicians, nurses, medical students, aides and volunteers. The company was founded by David Eagleman and Matthew Timberlake in 2009 and is headquartered in Houston, TX.

Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX.

BALX Holdings LLC operates as a biotechnology firm which offers health care services. The company was incorporated in 2013 and is headquartered in Boston, MA.

Celero Systems, Inc. is a life science company. It develops ingestible system to detect and reverse opioid overdose. The company was founded by Benjamin D. Pless, Carlo Giovanni Traverso, Robert S. Langer Jr., and Jeremy N. Ruskin and is headquartered in Lincoln, MA.

Anizome LLC is a private company based in Houston. The American company provides a description of their services in non-English text, which appears to be related to online sports betting and casino games.

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.

First Mile Care, Inc. is a preventative chronic care company that offers a no-cost prevention program to help avoid type 2 diabetes. The company is based in Menlo Park, CA and was founded by Karl Ronn, who has been the CEO since incorporation. The company enables physicians to extend their medical practices and reduce prediabetes risks by providing affordable, scalable, and sustainable solutions. First Mile Care helps physicians, participants, and coaches work together to improve health outcomes and prevent type 2 diabetes. Physicians prescribe the proven prevention program, while Medicare covers the costs. First Mile Care provides the latest affordable, scalable, and sustainable resources for preventing chronic conditions such as prediabetes.

Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen.

Mabvista, Inc. is a biotechnology firm that specializes in producing monoclonal antibodies. The company is based in Houston, TX.

Part of American Medical Association, Health2047, Inc. is a healthcare transformation company based in Menlo Park, CA. The company focuses on systemic transformation in the areas of data, chronic disease, and productivity to make healthcare more affordable, equitable, and with better outcomes. Health2047 invests in early-stage companies and provides a world-class network of entrepreneurs and mentors. Lawrence K. Cohen has been the CEO of the company since 2017.

Woodside Medical Management LLC is a medical clinic located in Monticello, AR that provides top-quality healthcare services to its clients. The American company focuses on patient-provider interaction, access to health information, and responsive staff to ensure efficient healthcare delivery. The clinic offers cosmetic laser services such as laser hair removal, anti-aging treatments, vein appearance alleviation, pigmentation reduction, and clearer skin with Lumecca. The private company was founded by Allan W. May.

InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation.